The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Drug Approval

This is a "connection" page, showing publications Andrzej Jakubowiak has written about Drug Approval.
Connection Strength

0.116
  1. Evolution of carfilzomib dose and schedule in patients with multiple myeloma: a historical overview. Cancer Treat Rev. 2014 Jul; 40(6):781-90.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.